How I assess comorbidities before hematopoietic cell transplantation

Area of Science:

• Hematology
• Oncology
• Transplantation Medicine

Background:

• The Hematopoietic Cell Transplantation-Comorbidity Index (HCT-CI) is crucial for assessing patient severity before HCT.
• Previous studies show inconsistent HCT-CI scoring among evaluators, impacting its reliability.
• Concerns exist regarding the consistency of comorbidity coding with the HCT-CI.

Purpose of the Study:

• To evaluate interobserver agreement in HCT-CI scoring.
• To develop and validate a training program to improve HCT-CI scoring consistency.
• To standardize comorbidity assessment for predicting HCT outcomes.

Main Methods:

• Assessed comorbidity scoring consistency across different evaluators.
• Developed a training program with systematic data acquisition and coding guidelines.
• Utilized a Web-based calculator to summarize guidelines.
• Validated the training program on a patient cohort.

Main Results:

• Initial testing revealed only fair interobserver agreement for HCT-CI scoring.
• The proposed training program improved interevaluator agreement to excellent rates (weighted κ: 0.89–0.97).
• The training program demonstrated effectiveness in a validation cohort.

Conclusions:

• A brief training program can significantly enhance the reliability of HCT-CI scoring.
• Standardized HCT-CI assessment facilitates more accurate prediction of HCT outcomes.
• This approach supports consistent comorbidity evaluation in clinical practice and research.